KRO vs NEM

KRO exhibits severe financial weakness, anchored by a Piotroski F-Score of 2/9, indicating poor operational health and deteriorating fundamentals. The company transitioned from a profit in 2024 to a net loss of $110.9 million in 2025, driven by the cyclical downturn in the TiO2 market and unabsorbed fixed costs. Despite a low Price-to-Sales ratio and a strong current ratio, the company is plagued by negative profit margins and a consistent track record of missing earnings estimates (0/4 beats in the last year). With the current price of $7.21 trading significantly above the analyst target of $5.50, the risk-reward profile is unfavorable.

Newmont Corporation presents a dichotomy between strong operational fundamentals and significant valuation premiums. While the Piotroski F-Score of 4/9 indicates stable health and the balance sheet is pristine with a Debt/Equity ratio of 0.17, the stock trades at a substantial premium to its Graham Number ($66.88) and Intrinsic Value ($44.73). Recent quarterly earnings beats are impressive, yet bearish insider sentiment and a 0/100 technical trend suggest a lack of immediate conviction from internal stakeholders and market momentum. The overall outlook is neutral as strong profitability is offset by overvaluation and negative insider signals.